India covid-19 patient Health India

Covid-19: Bajaj Health gets DRDO license to make 2-DG drug

Reading now: 121
www.livemint.com

Bajaj Healthcare Limited specialises in manufacturing of Amino Acids, Intermediates, API, formulations & Nutraceuticals.

The government has recently launched 2-DG as an anti -Covid-19 therapeutic application of the drug 2-Deoxy-D-glucose. Patients treated with 2-DG have shown negative RT-PCR in COVID-19 patients.

The drug can be administered only upon prescription and under the supervision of a qualified physician to 'hospitalised moderate to severe Covid-19 patients' as an adjunct therapy to the existing standard of care, Dr Reddy's said.

The 2-DG drug comes in powder form in the sachet, which is taken orally by dissolving it in water. It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA